One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Issue Information
doi : 10.1111/ijd.17853
International Journal of Dermatology: Volume 64, Issue 6
Inflammatory Nail Disorders in Skin of Color: A Systematic Review of Clinical and Onychoscopic Manifestations
doi : 10.1111/ijd.17680
Germline mutations predisposing to melanoma and associated malignancies and syndromes: a narrative review
doi : 10.1111/ijd.17602
Mohs Micrographic Surgery Versus Wide Local Excision in the Treatment of Anogenital Squamous Cell Carcinoma: A Systematic Review
doi : 10.1111/ijd.17689
Early Use of Beneficial Biological Therapy on Younger Psoriasis Patients: Could a ‘Step-Down’ Therapy Approach Be More Effective?
doi : 10.1111/ijd.17704
Baseline trichoscopic values for afro-textured hair in indigenous South Africans show lower density and unique features
doi : 10.1111/ijd.17633
Cutaneous Side Effects of PD-1 Inhibitors: A Single-Center Retrospective Study
doi : 10.1111/ijd.17683
Unveiling hidden leprosy in underserved populations of the Amazonas state through active case-finding—the Amazon Skin Health Program (2023)
doi : 10.1111/ijd.17628
Protective effects of BCG vaccination against multibacillary disease, reactions, and disabilities in childhood leprosy: Insights from a retrospective observational study from a tertiary care center in India
doi : 10.1111/ijd.17636
Single-center experience with bimekizumab in psoriasis patients with previous exposure to interleukin-17 inhibitors
doi : 10.1111/ijd.17630
Real-World Experience Using Bimekizumab in a Patient Cohort With Plaque-Type Psoriasis and Chronic Kidney Disease: A 48-Week Retrospective Multicentre Study
doi : 10.1111/ijd.17657
Bimekizumab Treatment for Scalp Psoriasis: A 52-Week, Real-World, Retrospective Study
doi : 10.1111/ijd.17658
Vesicular syphilis mimicking subepidermal immunobullous disease: a case report
doi : 10.1111/ijd.17540
Treatment-refractory granulomatous reaction to microneedling with transepidermal drug delivery of vitamin C, niacinamide, and botanical extracts
doi : 10.1111/ijd.17542
Hydroa vacciniforme-like lymphoproliferative disorder in a Cook Island M�ori child
doi : 10.1111/ijd.17537
Axillary granular parakeratosis: successful response to combined treatment with topical antibiotic and retinoid
doi : 10.1111/ijd.17539
Atypical Spitz tumor: classic methods, new technologies, and the role of line-field confocal optical coherence tomography
doi : 10.1111/ijd.17538
Acute digital ischemia due to lupus vasculitis successfully treated with anifrolumab
doi : 10.1111/ijd.17545
Ethical considerations regarding patient privacy when employing artificial intelligence in dermatology
doi : 10.1111/ijd.17525
The efficacy of dupilumab in patients affected by atopic dermatitis who previously failed tralokinumab
doi : 10.1111/ijd.17611
Epidemiology of discoid lupus erythematosus among adults in the United States: a cross-sectional analysis
doi : 10.1111/ijd.17603
Palmoplantar keratoderma, knuckle pads, and syndactyly associated with a new missense variant in the SLURP1 gene
doi : 10.1111/ijd.17612
Enhanced disease-specific survival following Mohs micrographic surgery compared to wide local excision for sebaceous carcinoma: a national database study
doi : 10.1111/ijd.17608
Effectiveness and safety of combined dupilumab and risankizumab in concomitant atopic dermatitis and psoriasis
doi : 10.1111/ijd.17610
Dermatomyositis: a comparison of clinical and histopathologic findings in Black and White patients
doi : 10.1111/ijd.17609
Alopecia areata and the risk of insulin resistance: a systematic review and meta-analysis
doi : 10.1111/ijd.17614
Early Biologic Therapy in Young Psoriasis Patients: Evaluating the Step-Down Approach
doi : 10.1111/ijd.17757
Use of PPE gowns to avoid scabies infestation and a 3-day ivermectin therapy to reduce risk of spread of contagion
doi : 10.1111/ijd.17623
Correction to “Spesolimab: A Comprehensive Review on the Anti-IL-36 Receptor Antibody in Dermatology�
doi : 10.1111/ijd.17788
